Corpus Intelligence IC Memo — SCHEURER HOSPITAL 2026-04-26 15:42 UTC
IC Memo — SCHEURER HOSPITAL
Investment Committee Memorandum | MI | 25 beds | Grade C | EBITDA uplift $4.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SCHEURER HOSPITAL

CCN 231310 | HURON, MI | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SCHEURER HOSPITAL is a 25-bed rural/critical access in HURON, MI with $55.6M in net patient revenue and a -5.1% operating margin. The hospital serves a payer mix of 56.9% Medicare, 0.4% Medicaid, and 42.7% commercial.

Thesis: Turnaround. Our ML models identify $4.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.1% to 2.3% (+736bps).

Net Revenue HCRIS$55.6M
Current EBITDA COMPUTED$-2.8M
Operating Margin COMPUTED-5.1%
Occupancy HCRIS17.7%
Revenue / Bed COMPUTED$2.2M
Net-to-Gross HCRIS61.3%
Distress Probability ML57.6%

2. Market Context & Competitive Position

163
MI Hospitals
-5.2%
State Median Margin
72
Comparable Hospitals

MI has 163 Medicare-certified hospitals with a median operating margin of -5.2%. The target's margin of -5.1% places it above the state median. Among 72 size-comparable peers (12-50 beds), the median margin is -3.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 72 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SCHEURER HOSPITAL (Target)MI25$55.6M-5.1%
TRINITY HEALTH LIVINGSTONMI42$200.4M15.2%
MYMICHIGAN MEDICAL CENTER ALMAMI49$142.2M-5.9%
SPECTRUM HEALTH UNITED MEMORIAMI45$129.4M9.7%
DICKINSON COUNTY HEALTHCARE SYMI49$126.3M-4.7%
MUNSON HEALTHCARE CADILLAC HOSMI49$122.7M1.0%
MCLAREN CENTRAL MICHIGANMI49$118.9M-35.3%
SPECTRUM HEALTH GERBERMI25$116.2M16.0%
SPECTRUM HEALTH LUDINGTONMI45$110.1M5.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.2M+210bp18mo
Cost to Collect4.5%2.5%$1.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$677K+122bp9mo
Clean Claim Rate88.0%96.0%$36K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.2M
Cost to Collect
$1.1M
Denial Rate Reduction
$1.1M
A/R Days Reduction
$677K
Clean Claim Rate
$36K
Total EBITDA Uplift$4.1M
Current EBITDA$-2.8M
+ RCM Uplift+$4.1M
Pro Forma EBITDA$1.3M
Current Margin-5.1%
Pro Forma Margin2.3%
WC Released (1x)$2.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-4.3M$22.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-4.3M$23.2M0.00x-100.0%
Bull Case9.0x11.0x$-3.9M$35.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.9M$37.3M0.00x-100.0%
Bear Case11.0x10.0x$-4.8M$3.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.8M$2.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 56.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 17.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 72 hospitals with 12-50 beds
  • Same-state prioritization (n=73)
  • Comp margins: P25=-11.8% / P50=-3.3% / P75=8.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.